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Summary Nosocomial infective endocarditis (NIE) is a relatively uncommon but nev-
ertheless a serious complication affecting critically ill hospitalized patients who are
frequently exposed to life-saving invasive procedures. We report three cases of NIE
in a tertiary-care hospital encountered during a period of two years. The ﬁrst case
developed in a 50% burn-injured patient; the second in a liver transplant recipient;
and the third in a renal transplant recipient. All patients met indications for car-
diac surgical intervention, however, the patient who had received a liver transplant
(case 2) was considered a poor candidate and unﬁt for surgery; she subsequently
died. The other two patients underwent open-heart surgery. The burns patient (case
1) survived; conversely, the renal transplant recipient (case 3) died postoperatively.
We have reviewed the literature concerning NIE in critically ill patients and describe
the epidemiology, microbiology and clinical features of this uncommon infection and
comment on its diagnosis and management.
© 2004 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
Introduction
Nosocomial infections are an ever-increasing prob-
lem, with an estimated 2.5 million cases affecting
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more than two million patients every year in the
United States, at a cost of $4.5 billion.1 Currently,
between 5—10% of patients admitted to acute care
hospitals acquire one or more infections.2 Nosoco-
mial infections affect a large percentage of criti-
cally ill patients admitted to intensive care units
(ICUs). It is the requirement for multiple life-saving
invasive procedures, such as central venous access,
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endotracheal intubation, and indwelling urinary
catheters which cause defects in the intrinsic barri-
ers to microbial invasion and increase susceptibility
to infection. Studies have shown that 21.2—35.6%
of ICU patients develop an infection during their
stay in ICU.3 Using the standard deﬁnitions for noso-
comial infections,4 several reports have revealed
that pneumonia is the most common nosocomial
infection, followed by urinary tract infections and
bloodstream infections.3,5 Nosocomial infective
endocarditis (NIE), both in native and prosthetic
valves, is a less common infection.3 However, it is
a well known complication, developing in seriously
ill hospitalized patients who require numerous in-
vasive procedures.6 Few studies have reported on
hospital-acquired infective endocarditis,7—9 and
only one has focused on NIE in ICU patients.10 Fi-
nally, studies that have reviewed cases of NIE in
solid organ transplant recipients11,12 and in burns
patients13,14 are also limited.
We report three cases of hospital-acquired infec-
tive endocarditis; two in solid organ transplant re-
cipients and one following a major burn injury, in a
mixed medical/surgical tertiary care ICU (King Fa-
had National Guard Hospital, Riyadh, Kingdom of
Saudi Arabia). These cases were encountered over a
two-year period from 2000—2001. During this time
there were 1298 admissions to the ICU, constituting
0.23% of all ICU admissions.
Case reports
Patient 1
A 33-year-old woman was admitted with 50%
total body surface area full thickness burns.
Both burn wounds and airway became colonized
with methicillin-resistant Staphylococcus aureus
(MRSA). In her ﬁfth month of hospitalization and
on the second postoperative day of burn wound
debridement with skin grafting, she developed a
high fever of 39.5 ◦C. Two blood cultures grew
MRSA. Antibiotic therapy was started with intra-
venous vancomycin. Repeat blood cultures ﬁve
days after antibiotic treatment remained positive
for MRSA. All intravascular devices were changed
and a transthoracic echocardiography (TTE) did not
show vegetations. A transesophageal echocardio-
graph (TEE) was performed which showed a large
mitral valve vegetation, perforation of the anterior
leaﬂet, and severe mitral regurgitation, conﬁrming
the diagnosis of NIE. She underwent emergency
open-heart surgery for mitral valve replacement.
The culture from the 3 cm vegetation was positive
for MRSA. The patient improved and was discharged
later from the hospital.
Patient 2
A 48-year-old female with a liver transplant was
readmitted to the ICU for septic shock in her third
month of hospitalization. Central venous line sep-
sis was suspected. Two peripheral blood cultures
and the tip of central line grewmethicillin-sensitive
Staphylococcus aureus. Intravenous cloxacillin was
administered. A TTE showed thickened mitral and
aortic valves with mitral and aortic regurgitation.
Although rifampin was added and all intravascu-
lar devices were changed she developed persistent
Staphylococcus aureus bacteremia and daily blood
cultures remained positive for the same organism
for ﬁve consecutive days. A TEE showed a mitral
valve vegetation with an annular abscess and perfo-
ration. Early surgical intervention was entertained
for the treatment of the paravalvular abscess. How-
ever, she was considered a poor candidate for car-
diac surgery because of her poor general condi-
tion with multi-organ failure and she subsequently
died.
Patient 3
A 52-year-old male renal transplant recipient was
readmitted with a presumptive diagnosis of cy-
tomegalovirus chorioretinitis six weeks after dis-
charge. On the second hospital day he was admitted
to ICU for confusion and change in his mental sta-
tus. A CT scan of the head revealed a hemorrhagic
cerebral infarct. A pan-systolic heart murmur was
detected. Infective endocarditis complicated by an
embolic cerebral infarct was suspected. A TTE was
suggestive of endocarditis. A TEE was performed
and showed a large vegetation with rupture of the
mitral valve. As all blood cultures were negative,
the diagnosis of culture-negative endocarditis was
made. Antibiotic therapy was started with intra-
venous ceftazidime, clindamycin, and gentamicin.
Considering the large vegetation size and the nega-
tive blood cultures with lack of response to the an-
tibiotic therapy, fungal endocarditis was suspected.
Empiric antifungal therapy was initiated with am-
photericin B. Although the patient was in serious
general condition and had multi-organ failure, he
underwent open-heart surgery for mitral valve re-
placement. He died on the second postoperative
day. The pathology of the mitral valve vegetation
specimen showed fungal infective endocarditis.
The culture specimen grew Aspergillus spp.
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Discussion
Nosocomial infective endocarditis continues to be
considered a serious problem and a life-threatening
disease. Although signiﬁcant progress has been
made in both diagnosis and treatment, NIE is still
associated with prolonged hospital stay, increased
morbidity, mortality and medical costs.
Deﬁnition
Nosocomial infective endocarditis is deﬁned
as acute IE occurring 48 to 72 hours or more
post-admission to hospital and/or endocarditis di-
rectly relating to a hospital-based procedure per-
formed during a previous hospital stay within eight
weeks of admission.8—10 Early prosthetic valve en-
docarditis (PVE) is therefore included, based on the
latter deﬁnition. However, others usually exclude
cases of early PVE from NIE and deﬁne them as IE
occurring within the ﬁrst year after valve replace-
ment and thought to be acquired in the operating
room or during the perioperative period.15
Epidemiology
Nosocomial infective endocarditis has been consid-
ered to be a rather infrequent hospital-acquired in-
fection representing 0.1% of nosocomial infections.
It is encountered as a rare entity in critically ill pa-
tients. However, the exact incidence of NIE in ICU
settings is not well known. In the only existing study
of NIE in the ICU, NIE was identiﬁed in 0.8% of pa-
tients admitted to a medical ICU.6
Approximately 7.5% to 29% of all cases of IE
seen in tertiary hospitals have been nosocomially
acquired,7,8,16 compared to 14% to 25% in commu-
nity hospitals.17 Over the past few decades, there
has been a worldwide increase in the number of
cases of NIE. Fernandez-Guerrero et al. found that
NIE accounted for 9.3% of all episodes of IE di-
agnosed over a 15-year period (1978—1992) in a
tertiary-care hospital with a ten-fold increase in
the number of cases of NIE in comparison to the
historical control cases of IE treated at the same
hospital from 1960 to 1975.9 This increase in the
incidence of NIE is attributed to various reasons in-
cluding the widespread use of invasive procedures,
the growing population of elderly patients with de-
generative valvular heart disease and/or prosthetic
valves, and the improvement in the diagnosis of IE
with new diagnostic schema (the Duke criteria),18
utilizing echocardiographic data obtained predom-
inantly by TEE which has improved the detection
of IE.
The risk of NIE may well continue to rise in the
future, not only for the reasons mentioned above,
but also because of the growing numbers of ICU
beds admitting more elderly critically ill patients
and immunocompromized patients, who are surviv-
ing longer due to advancement in medical care.
Patient characteristics
Overall, more than 60% of patients with NIE are
male and they are often elderly. Approximately
two thirds of the patients are over the age of 60
years. Their mean age (55± 3.2 years8 to 65± 9
years10) is also greater than that of patients with
community-acquired infective endocarditis (only
21—29.5% of the latter are >60 years with a mean
age of 47.8± 1.5 years).8
Source of infection
Most cases of NIE are secondary to device-related
bacteremia.9 Central venous catheters account for
an estimated 90% of all catheter-related blood-
stream infections.19 Therefore, the most common
source of infection resulting in NIE is an intravascu-
lar catheter or another intravascular device, being
implicated in 45.5—56.5% of episodes of NIE.8—10
Cases of catheter-related NIE (CR-NIE) have been
associated with all kinds of intravascular devices;
9.1—48% of episodes of CR-NIE were associated
with central venous catheters, 6—22.7% with pe-
ripheral venous catheters, 2—9% with central ar-
terial catheters (pulmonary artery catheters) and
a substantially lower incidence with peripheral ar-
terial catheters and hemodialysis catheters. The
duration of catheterization was a major risk fac-
tor for CR-NIE. In all cases of CR-NIE reported
by Fernandez-Guerrero et al., the implicated
catheters had been in place for >78 hours (5—10
days in 68% of cases).9 Other sources of infections
resulting in NIE have been: surgical wounds; surgical
procedures or instrumentation of the genitourinary
tract, heart, gastrointestinal or tracheal tract; and
skin and soft tissue lesions.8—10 The portal of entry
could not be identiﬁed in 0—17% of cases of NIE.20
Microbiology
The most frequently isolated pathogens in NIE
are staphylococci (77.4%), both S. aureus and
coagulase-negative staphylococci.8 In more re-
cent reports, the organism causing NIE has been
predominantly S. aureus, being responsible for
52—57% of cases.20 The link between intravascular
catheters and nosocomial S. aureus endocarditis is
well known and has been emphasized. Ninety-one
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percent of nosocomial S. aureus endocarditis is as-
sociated with an intravascular device as the most
probable portal of entry.8—10,21 Although not all
patients with intravascular device-associated S.
aureus bloodstream infections develop endocardi-
tis, the risk of developing this complication in such
patients is major. In 1997, a prospective study of
patients with S. aureus bloodstream infections by
Fowler et al. reported that 16 (23%) of 69 patients
with intravascular catheter-associated bloodstream
infections had endocarditis.22 The identiﬁcation of
catheter-related S. aureus bacteremia has signif-
icant clinical implications. Recently, Rosen et al.
recommended the use of TEE for all patients with
clinically uncomplicated (i.e. no clinical evidence
of endocarditis) catheter-related S. aureus bac-
teremia, to determine the duration of antibiotic
therapy. Considering the overall cost, he reported
that the use of TEE was cost effective in deter-
mining the choice between two or four weeks’
empirical antibiotic treatment.23
The second most common pathogen implicated
in NIE is Enterococcus spp, causing 5—30% of
cases.8,9,20 Enterococcal endocarditis frequently
originates from the genitourinary tract, which is
suspected to be the source of infection in 14—70%
of cases of NIE.24 Recent reports have documented
a steady increase in the incidence of nosocomial en-
terococcal bloodstream infections.25—27 However,
enterococcal endocarditis develops in a minority
of patients with enterococcal bacteremia. Elderly
patients and those with underlying vascular disease
seem to be at higher risk. Particularly alarming are
cases of NIE caused by strains of Enterococcus fae-
calis highly resistant to aminoglycosides,28 or by
multiresistant Enterococcus faecium.24,29,30
Fungal IE is a rare infection representing <10% of
IE cases.31 However, Gilleece and Fenelon observed
an increase in the incidence of fungal endocarditis
in the last decade.32 Candida spp. (both C. albicans
and non-albicans Candida), are the most common
pathogens involved in fungal NIE, followed by As-
pergillus spp. Predisposing factors for fungal endo-
carditis include prolonged antibiotic therapy, im-
munosuppressive therapy, central venous catheters
(mainly for total parenteral nutrition), pacemaker
implantation, disseminated fungal infection, previ-
ous cardiac surgery, prior or concomitant bacterial
endocarditis, and prosthetic heart valves. When-
ever Aspergillus spp, Histoplasma spp, and Mucor
spp are implicated, they rarely grow on routine
or fungal isolator media. Case 3 is a typical pre-
sentation. A kidney transplant recipient receiving
immunosuppressive therapy (cyclosporin and pred-
nisone) diagnosed initially with culture-negative
endocarditis, however the histopathology and the
culture conﬁrmed Aspergillus to be the causative
pathogen. Thus, fungal infection should be consid-
ered in critically ill immunocompromized patients
with culture-negative NIE.
Although Gram-negative bacteremia is common
in the hospital setting, Gram-negative bacilli are
infrequently involved in NIE, most likely because
of their decreased capability to adhere to heart
valves.32 Pseudomonas aeruginosa is the most fre-
quent Gram-negative organism implicated in NIE.
Patients on hemodialysis are at higher risk of devel-
oping Pseudomonas IE.
In a much earlier study, culture-negative IE ac-
counted for 5% of cases.33 Culture-negative NIE
was attributed to prior administration of antimicro-
bials, before blood cultures were drawn, especially
in patients who had been hospitalized for pro-
longed periods. In certain cases of fungal NIE, such
as Curvularia spp, Pencillium spp, and Phycomyces
spp, blood cultures were always negative.
The risk of fungal IE is increased in solid organ
transplant recipients. Paterson et al. found that
fungal infections were responsible for 28% of the 46
cases of IE in solid organ transplant recipients.11
Risk factors and cardiac involvement
Patients with predisposing heart conditions, such
as degenerative valvular disease, rheumatic valvu-
lopathy, prosthetic valves, and previous endocardi-
tis, are at high risk of developing NIE. Immuno-
compromized patients appear to be at especially
high risk. Forty percent of patients with NIE had no
known preexisting valvular disease. The predomi-
nance of left-sided NIE (mitral and aortic valves)
is attributed to the dominance of underlying valvu-
lar lesions, as well as preexisting prosthetic cardiac
valves in the left side of the heart. Right-sided in-
fections, mainly tricuspid valve NIE, are rare and
occur mostly in patients whose endocarditis is as-
sociated with an intravascular device such as pace-
maker or intravascular catheter.
Clinical features and diagnosis
In general, symptoms found at presentation in
patients with NIE are similar to those noted in
patients with community-acquired infective endo-
carditis (CIE). The most common clinical manifes-
tations are: fever, hypotension, new/changing car-
diac murmurs, chills, congestive heart failure with
pulmonary edema, tachycardia, and renal failure.
The clinical diagnosis of IE is surprisingly dif-
ﬁcult. This is due both to the inaccessibility of
intra-cardiac vegetations and to the highly variable
and sometimes non-speciﬁc nature of the clinical
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manifestations leading to a wide differential diag-
nosis. History, physical examination and laboratory
ﬁndings are frequently inconclusive. In patients
hospitalized in the ICU, diagnosing NIE can be even
more difﬁcult. The classical manifestations of en-
docarditis are not usually seen in critically ill pa-
tients. Central nervous system signs of endocarditis
are often blunted due to sedation. Fever and bac-
teremia are frequently attributed to other possible
co-existing hospital-acquired infections. Finally,
acute renal failure is common in ICU patients and
attributed to different mechanisms.
Echocardiographic diagnosis
Echocardiography is recognized as the method of
choice for the non-invasive identiﬁcation of valvu-
lar vegetations in patients with IE. It also gives valu-
able information on associated complications, such
as abscesses or perforations, as well as on cardiac
function. Echocardiographic detection of valvular
vegetation and/or an associated complication in pa-
tients with active IE not only conﬁrms the diagnosis
but also guides the timely institution of appropri-
ate therapy, including the need for surgical inter-
vention, and helps in determining prognosis.34,35
In the diagnosis of IE and its complications, trans-
esophageal echocardiography (TEE) is much more
sensitive than transthoracic echocardiography
(TTE) and has increased diagnostic accuracy.36,37
Although this is, in general, well known, it is proba-
bly more evident in ICU patients. The use of TTE is
often limited in ICU patients for many reasons, in-
cluding mechanical ventilation, chest wall edema,
subcutaneous emphysema, and dressings. TEE has
been recommended in all patients with intravas-
cular device-associated S. aureus bloodstream
infections.23,38
Outcome
Remarkable progress has been made in the manage-
ment of NIE during the last few decades, leading
to a decrease in the mortality rate from 82% in the
1960s7 to between 40.9—56.5% in the 1990s.8,9
The mortality rate is higher in more elderly pa-
tients compared with younger (50% vs. 25%), in S.
aureus and fungal IE, and in NIE compared with CIE
(40.9—56.5% vs. 18—26.5%).8,9,20 Although it is well
known that the outcome of patients with NIE is poor,
it is difﬁcult to make accurate estimates of mortal-
ity in the subgroup of critically ill patients with NIE.
Gouello et al. reported an overall mortality of 68%,
and death was directly associated with NIE in 36%
of cases.10
Surgical management is more frequently indi-
cated in critically ill patients with NIE than in other
patients with IE, and the majority of ICU patients
with NIE meet indications for cardiac surgery.10
However, most of these patients are in poor general
condition, at high risk for major operations and
therefore considered unﬁt for cardiac surgery. Con-
sequently, surgery can be undertaken only in a few,
selected patients. In the series of Gouello, of the
16 cases with surgical indications, only ﬁve patients
underwent surgery, and 11 did not as they were
unﬁt. The mortality rate was higher in the group of
patients in whom cardiac surgery was indicated but
could not be operated on because of poor general
conditions, than the group of patients who under-
went surgery (nine out of 11 vs. two out of ﬁve).10
In fact, this difference in mortality could be easily
explained by the more serious illnesses and poorer
condition of patients who were not candidates for
cardiac surgery. Although surgery is promising, the
beneﬁt is difﬁcult to evaluate and timing is unclear.
NIE in special populations
Solid organ transplant recipients, because of multi-
ple invasive procedures, prolonged hospitalization
and immunosuppressive therapy, are at high risk
of developing infectious complications such as bac-
teremia and, uncommonly, IE. Paterson et al. found
a prevalence of IE of 1.7% in a cohort of liver trans-
plant recipients. They quoted a study that reported
a prevalence of IE of 6% among heart transplant
recipients. Although previously reported cases in
kidney transplant recipients are relatively numer-
ous, they found no data from which the prevalence
of endocarditis could be calculated among these
patients.11
Solid organ transplant recipients with IE vary
from other patients with IE in many aspects.11
Their mean age is lower (46 years; range 12—67
years). Most patients have no history of valvular
disease or abnormality. The majority of cases are
nosocomially-acquired (74% NIE vs. 26% CIE). The
spectrum of causative organisms is evidently dif-
ferent: bacterial in 72% and fungal in 28%. Staphy-
lococcus aureus and Aspergillus fumigatus are the
most common organisms, being responsible for
about 50% of cases (31% and 18% respectively). Fi-
nally, among these patients the mortality rate is
high (64%).11
NIE is an uncommon but grave complication
following major burn injury. Burn wound manip-
ulation is the most likely source of bacteremia
and consequently NIE. Staphylococcus aureus and
Gram-negative bacilli are the most frequently im-
plicated organisms. Presentation is characteristi-
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cally silent, with persistent fever and positive blood
cultures. Usually, NIE in burn patients is associated
with a high mortality rate.13,39
Conclusion
In summary, NIE in critically ill patients represents
an unique entity. Considering its rare occurrence
and the multiple confounding symptoms and signs
in this group of patients, the diagnosis can be dif-
ﬁcult, delayed, or even missed. NIE in critically
ill patients has serious consequences leading to
multi-organ failure, which can further complicate
the clinical picture as well as the management.
Underlying immunosuppression appears to predis-
pose to this infection. Unusual organisms such as
Aspergillus spp, although rare, can be responsible
and should be considered in critically ill patients
with high clinical suspicion of NIE but with negative
blood cultures. More importantly, the prior admin-
istration of antimicrobials before blood cultures are
drawn is a more likely etiology of culture-negative
endocarditis in the critical case. Although the ma-
jority of critically ill patients with NIE meet indica-
tions for surgery, many of them are considered too
ill and unsuitable for cardiac surgery. But patients
who undergo surgical intervention appear to have
a better outcome.
Finally, because of its high mortality, prevention
needs to be emphasized; patients at risk should be
identiﬁed and measures for prophylaxis and care of
intravascular devices and other invasive procedures
must be implemented.
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